RenaSci Consultancy Limited - Limited company - abbreviated - 11.6

RenaSci Consultancy Limited - Limited company - abbreviated - 11.6


04157254 1.4.14 31.3.15 31.3.15 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure041572542014-03-31041572542015-03-31041572542014-04-012015-03-31041572542013-03-31041572542013-04-012014-03-31041572542014-03-3104157254ns12:England2014-04-012015-03-3104157254ns14:PoundSterling2014-04-012015-03-3104157254ns7:Director12014-04-012015-03-3104157254ns7:Director22014-04-012015-03-3104157254ns7:OrdinaryShareClass12014-04-012015-03-3104157254ns7:Director32014-04-012015-03-3104157254ns7:CompanySecretary2014-04-012015-03-3104157254ns7:RegisteredOffice2014-04-012015-03-3104157254ns7:EntityAccountantsOrAuditors2014-04-012015-03-3104157254ns7:OrdinaryShareClass12015-03-3104157254ns7:OrdinaryShareClass12014-03-31
REGISTERED NUMBER: 04157254 (England and Wales)












Abbreviated Unaudited Accounts

for the Year Ended 31 March 2015

for

RenaSci Consultancy Limited

RenaSci Consultancy Limited (Registered number: 04157254)






Contents of the Abbreviated Accounts
for the Year Ended 31 March 2015




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

RenaSci Consultancy Limited

Company Information
for the Year Ended 31 March 2015







DIRECTORS: Dr R B Jones
Dr S C Cheetham
Dr D J Heal





SECRETARY: Dr R B Jones





REGISTERED OFFICE: Coburg House
1 Coburg Street
Gateshead
Tyne and Wear
NE8 1NS





REGISTERED NUMBER: 04157254 (England and Wales)





ACCOUNTANTS: RHK Business Advisers LLP
Chartered Accountants
and Business Advisers
Coburg House
1 Coburg Street
Gateshead
Tyne & Wear
NE8 1NS

RenaSci Consultancy Limited (Registered number: 04157254)

Abbreviated Balance Sheet
31 March 2015

2015 2014
Notes £    £   
CURRENT ASSETS
Debtors 620,400 620,400
TOTAL ASSETS LESS CURRENT
LIABILITIES

620,400

620,400

CAPITAL AND RESERVES
Called up share capital 2 620,400 620,400
SHAREHOLDERS' FUNDS 620,400 620,400

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the
end of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 15 September 2015 and were signed on its
behalf by:




Dr D J Heal - Director



Dr R B Jones - Director


RenaSci Consultancy Limited (Registered number: 04157254)

Notes to the Abbreviated Accounts
for the Year Ended 31 March 2015

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

The company was dormant throughout the current year and previous year.

Deferred tax
The charge for taxation takes into account taxation deferred as a result of timing differences between the
treatment of certain items for taxation and accounting purposes. In general, deferred taxation is recognised
in respect of all timing differences that have originated but not reversed at the balance sheet date. However,
deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred taxation is measured on a non-discounted basis at the average tax rates that would apply when the
timing differences are expected to reverse, based on tax rates and laws that have been enacted by the
balance sheet date.

Research and development
Expenditure on research and development is written off in the year in which it is incurred, except for
expenditure on related assets, which are disclosed in these financial statements as intangible assets, and
written off over the expected useful life of those assets.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating
result.

Government grant
Government grants received in respect of expenditure charged to the profit and loss account during the year
have been included in the profit and loss. The remainder are deferred and included in the profit and loss
account by instalments over the expected useful lives of the related assets.

2. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2015 2014
value: £    £   
620,400 Ordinary £1 620,400 620,400

3. ULTIMATE PARENT COMPANY

The company's ultimate parent undertaking at the balance sheet date is RenaSci Limited, a company
incorporated in the United Kingdom.